Study groups
|
Lab. Code
|
Age/sex
|
Virological characteristics
|
Clinical characteristics
|
---|
Anti-HCV
|
HIV status
|
HBV viral load
|
HBeAg
|
HBV genotype
|
HDV viral load
|
HDV genotype
|
---|
HIV co-infected
|
ETH3790
|
34/M
|
Neg
|
Pos
|
3.62
|
Neg
a
|
A1
|
9.67 × 10
6
|
I
|
WHO stage I
|
ETH2170
|
36/F
|
Pos
|
Pos
|
Un
|
Pos
|
–
|
2.27 × 10
5
|
I
|
WHO stage IV
|
ETH2280
|
33/M
|
Neg
|
Pos
|
Un
|
Neg
|
–
|
7.08 × 10
7
|
I
|
WHO stage I
|
ETH1480
|
37/F
|
Neg
|
Pos
|
2.72
|
Neg
|
D2
|
–
|
–
|
WHO stage II
|
ETH1570
|
57/F
|
Neg
|
Pos
|
8.93
|
Neg
|
A1
|
–
|
–
|
WHO stage I
|
ETH4500
|
30/F
|
Pos
|
Pos
|
3.08
|
Neg
|
D4
|
–
|
–
|
WHO stage II
|
ETH1470
|
31/M
|
Pos
|
Pos
|
0.48
|
Neg
|
–
|
–
|
–
|
WHO stage I
|
ETH2590
|
38/F
|
Neg
|
Pos
|
Un
|
Neg
|
–
|
–
|
–
|
WHO stage I
|
ETH2570
|
46/M
|
Neg
|
Pos
|
Un
|
Neg
|
–
|
–
|
–
|
WHO stage I
|
ETH2150
|
49/F
|
Neg
|
Pos
|
Un
|
Neg
|
–
|
–
|
–
|
WHO stage I
|
CLD patients
|
ETH4060
|
60/M
|
Neg
|
Neg
|
6.34
|
Neg
|
A1
|
3.01 × 10
5
|
I
|
Liver cirrhosis
|
ETH4100
|
33/M
|
Neg
|
Neg
|
3.15
|
Neg
|
A1
|
2.28 × 10
5
|
I
|
HCC
|
ETH3020
|
21/F
|
Neg
|
Pos
|
6.90
|
Pos
|
A1
|
–
|
–
| |
ETH3700
|
25/M
|
Neg
|
Neg
|
7.60
|
Pos
|
A1
|
–
|
–
|
Liver ascites + cirrhosisa
|
ETH4070
|
23/M
|
Neg
|
Neg
|
4.04
|
Neg
|
D3
|
–
|
–
| |
ETH5730
|
45/M
|
Neg
|
Neg
|
4.47
|
Neg
|
D2
|
–
|
–
|
Chronic hepatitisb
|
ETH3080
|
38/F
|
Neg
|
Neg
|
0.60
|
Nd
|
–
|
–
|
–
|
Chronic hepatitisc
|
ETH3120
|
64/M
|
Neg
|
Neg
|
6.81
|
Pos
|
A1
|
–
|
–
| |
ETH3190
|
45/M
|
Neg
|
Neg
|
1.56
|
Neg
|
–
|
–
|
–
|
Chronic hepatitisd
|
ETH3320
|
52/M
|
Neg
|
Neg
|
1.00
|
Nd
|
–
|
–
|
–
|
Liver cirrhosisa
|
ETH3360
|
22/M
|
Neg
|
Neg
|
0.78
|
Neg
|
–
|
–
|
–
| |
ETH4390
|
27/M
|
Pos
|
Neg
|
2.01
|
Neg
|
–
|
–
|
–
| |
ETH4380
|
28/M
|
Pos
|
Neg
|
Un
|
Neg
|
–
|
2.41 × 102
|
–
|
Chronic hepatitise
|
Blood donors
|
ETH2056
|
47/M
|
Neg
|
Neg
|
8.39
|
Neg
|
D2
|
6.55 × 10
5
|
I
|
–
|
ETH5660
|
55/M
|
Neg
|
Neg
|
0.78
|
Nega
|
–
|
–
|
–
|
–
|
ETH5650
|
38/M
|
Pos
|
Neg
|
Un
|
Nd
|
–
|
–
|
–
|
–
|
- Highlighted in bold rows indicate study subjects of their HDV isolate was sequenced. WHO World Health Organization HIV infection disease staging, aBoth HBeAg and HBeAb tests showed non-reactive, bComplicated with schistosomiasis and Hookworm infections, cComplicated with H.pylori infections, dDiagnosed for hepatosplenic and hepatosplenomegaly associated schistosomiasis, e Complicated with Ascaris, Hookworm and P.falciparum infections. Note: Chronic liver disease (CLD) patients with no specified clinical characteristics were classified as ‘undefined’ liver sign and symptoms. Un-undetected. Nd-not done (insufficient sample). HCC-Hepatocellular carcinoma